Psychotropic medication patterns among youth in foster care. - Wikidata - wikimedia - TriplyDB

Psychotropic medication patterns among youth in foster care.

Psychotropic medication patterns among youth in foster care.

http://www.wikidata.org/entity/Q34731951

about

Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring Pediatric bipolar disorder in an era of "mindless psychiatry"Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data Use of Psychotropic Medications among Youth in Treatment Foster Care.Racial/ethnic differences in Medicaid expenditures on psychotropic medications among maltreated children Rates of psychotropic medication use over time among youth in child welfare/child protective services.State variation in psychotropic medication use by foster care children with autism spectrum disorder.Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges.The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states.Adverse effects of psychotropic medications in children: predictive factors Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.Stimulant and atypical antipsychotic medications for children placed in foster homes.Globalization and cognitive enhancement: emerging social and ethical challenges for ADHD clinicians.Impact of physical and sexual abuse on treatment response in the Treatment of Resistant Depression in Adolescent Study (TORDIA).Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents Review: Adoption, fostering, and the needs of looked-after and adopted children.Unplanned medication discontinuation as a potential pharmacovigilance signal: a nested young person cohort study Medicaid expenditures on psychotropic medications for maltreated children: a study of 36 States.A translational neuroscience perspective on the importance of reducing placement instability among foster children.Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression.The neurobiology of psychopathic traits in youths.Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychotics Biologism in Psychiatry: A Young Man's Experience of Being Diagnosed with "Pediatric Bipolar Disorder".Foster care, externalizing disorders, and antipsychotic use among Medicaid-enrolled youths.Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008 Medicaid expenditures on psychotropic medications for children in the child welfare system Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs.Antipsychotic treatment among youth in foster care.The role of parent characteristics in community-based medication treatment for children with disruptive behavior problems.Second-generation antipsychotic use among stimulant-using children, by organization of medicaid mental health.Demographic and placement variables associated with overweight and obesity in children in long-term foster care.Weight changes in children in foster care for 1 year.Antipsychotic medication prescribing trends in children and adolescents.Multiple psychiatric diagnoses common in privately insured children on atypical antipsychotics.Pioneering the psychiatric nurse role in foster care.Reduced activity within the dorsal endogenous orienting of attention network to fearful expressions in youth with disruptive behavior disorders and psychopathic traits.Prescription of psychiatric medications and polypharmacy in the LAMS cohort.Interstate variations in psychotropic medication use among a national sample of children in the child welfare system.After out-of-home mental health treatment: atypical antipsychotic medication use and the probability of returning to treatment.

P2860

Q21202071-1557A493-3DA5-4EDD-9A47-11DDAB01BD13 Q26864304-704FA588-86B5-43F3-8A07-C4F7B4243DCB Q28295134-62C54B82-FC29-4148-9310-B3D897C61133 Q30887709-3FE6C57A-EA32-40E5-8FBC-928326C844EC Q33699936-B5CA08C4-96FF-4207-9A0B-238774D53DDB Q33769706-54F546A1-AE20-4139-8D02-587B48D8BE6C Q33832794-62556AED-1983-4991-9B93-97C467F01BF3 Q33857711-FE6F92D5-F1B6-49F3-A0F7-1B08E8D95910 Q33960193-D6C66F0D-9BC6-443B-A664-6F1A75B6280E Q34171640-6D5AD384-7A3F-4311-8B3C-1D4691E5A34F Q34341232-0A2ECDB4-0A0D-4C40-A4F1-D02EE6DC0A48 Q34424843-A06EEF63-A359-46BE-8AFE-FD2E699EC2E6 Q34552192-0FD0C5B7-8C2A-49C2-A85A-6C038183BD61 Q34655248-30AA42CD-A40C-44E5-BBD2-4B787D88F206 Q34777571-9360E326-2B4E-480E-BDEE-447B7FFA578F Q34831800-0CECC449-CA0B-4262-A75E-53295807C2D4 Q35064006-53A2A828-F25C-499C-979F-7DB8FA22A412 Q35110509-879945FA-180D-4B4E-B8BF-75A1A8F1D544 Q35137779-B41AD66E-15DA-42A6-835A-FD3A03D2AB6C Q35412642-E475A0B2-C7D1-44C4-B6E5-8438B56ADB0C Q35483556-C84785F7-BEEC-4F2F-80DC-00FDC7EC28CA Q35565713-BA8D76B9-1372-410B-8B12-29545ACE4C27 Q35641776-A6A0F978-CF17-4F90-B212-C848C63A0AB8 Q35667265-0F54C896-F056-4DFF-A086-43D7D8E1C74B Q35809854-213B4CAF-0E34-4CB1-8C60-64CB257215BF Q35962531-D865ECCF-FB8D-435D-8E6D-C90BD2E76641 Q36026838-00EA48F7-0CC8-4651-A1FD-AFA89D719B7B Q36063735-FED0EFA3-9EF4-4472-BE90-6D320CA7BA3E Q36071218-89DBF5FC-2B1A-4DFB-B2F7-67FA91732787 Q36454422-E225714B-37C8-4D2C-B83C-F29B0A65748E Q36591575-6BFC2DC4-B91E-4FAB-B2D6-59A950954D35 Q36650959-52FB3405-88C7-4CD5-8C52-BBF557D012EF Q37018392-FEEBDC28-3B97-47FF-BD71-855D16D4714F Q37185017-06681892-0A3A-4185-A4F9-5B602EA79482 Q37254197-AF7F5F03-EB63-4326-B210-2E3EF23390D2 Q37352482-1B882657-A31E-4AA6-8B77-F49E5BBAAA06 Q37615994-DAAD41C4-CC2E-429F-AF37-177ED51D402A Q37688553-D3804B7C-DBAA-46AB-95D3-B343521F2899 Q37735535-E83AD734-E1AC-4928-9A1C-AC367BDFDE04 Q37920762-69543EEC-9660-415C-A434-020D8DBE342B

P2860

Psychotropic medication patterns among youth in foster care.

http://www.wikidata.org/entity/Q34731951

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Psychotropic medication patterns among youth in foster care.

@ast

Psychotropic medication patterns among youth in foster care.

@en

Psychotropic medication patterns among youth in foster care.

@nl

type

label

Psychotropic medication patterns among youth in foster care.

@ast

Psychotropic medication patterns among youth in foster care.

@en

Psychotropic medication patterns among youth in foster care.

@nl

prefLabel

Psychotropic medication patterns among youth in foster care.

@ast

Psychotropic medication patterns among youth in foster care.

@en

Psychotropic medication patterns among youth in foster care.

@nl

P1433

Q34731951-7BE019AC-7FBD-4992-BF4C-8C841A80CC00

P1476

Q34731951-053EBB4F-F266-4648-BEEF-7F7EB5E8078A

P2093

Q34731951-0644177E-2A2F-4308-A20B-FE8C040AFE25

Q34731951-2EFFA438-8A38-468B-8C97-E81DE9F5ACBF

Q34731951-3FD29CDA-E922-4349-AC41-2C69922964BB

Q34731951-499832C9-BCC1-417C-AC63-FB377BA05693

Q34731951-6FDDD316-70B2-4F67-90F1-B26F72E6F19E

Q34731951-8F4DE843-10F6-479C-B365-01F2464EE44D

Q34731951-C8AE0ADF-C9AE-4760-A55C-B333A7DF2098

Q34731951-DE712230-D42E-4182-B826-6D134ACF8B2E

P304

Q34731951-508B22BA-B877-4F56-AF56-394ECE8EA5C8

P31

Q34731951-24E30DAD-3054-4F0F-AAD5-0EDF69B2676C

P356

Q34731951-7633D4B6-8838-408F-B4B6-F2D0CE216051

P407

Q34731951-59BBA208-9ADE-4567-B1B8-FFB62EC7FB38

P433

Q34731951-15448D82-CE83-41C0-A9F7-169A9E45C0A1

P478

Q34731951-D40F180C-F210-4020-A043-36C62CF15959

P577

Q34731951-F56BF516-4B89-4014-86D5-29F46AE8C463

P5875

Q34731951-67BAD195-CA9C-4E5B-A997-0A761D1BB6BA

P698

Q34731951-6E090838-7C4E-4F8D-9BFE-15C5986758A9

P356

P1433

P1476

Psychotropic medication patterns among youth in foster care.

@en

P2093

Daniel J Safer

http://www.w3.org/2001/XMLSchema#string

Devadatta Sai

http://www.w3.org/2001/XMLSchema#string

Diane Thomas

http://www.w3.org/2001/XMLSchema#string

James F Gardner

http://www.w3.org/2001/XMLSchema#string

Julie M Zito

http://www.w3.org/2001/XMLSchema#string

Maria Mendez-Lewis

http://www.w3.org/2001/XMLSchema#string

Melissa Dubowski

http://www.w3.org/2001/XMLSchema#string

Phyllis Coombes

http://www.w3.org/2001/XMLSchema#string

P304

e157-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2007-0212

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5682279

http://www.w3.org/2001/XMLSchema#string

P698

18166534

http://www.w3.org/2001/XMLSchema#string